What should be done for an adult with potential underlying health conditions such as hypertension, diabetes, or glaucoma diagnosed with a blood clot in the retina of one eye?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Retinal Blood Clot (Retinal Vascular Occlusion)

If you are diagnosed with a blood clot in the retina, you need urgent ophthalmologic evaluation within 24-48 hours to determine whether this is a retinal vein occlusion (RVO) or retinal artery occlusion (RAO), followed by immediate systemic workup to prevent stroke and vision loss in the other eye. 1

Immediate Actions Required

Emergency Evaluation for Arterial Occlusion

  • If this is a retinal artery occlusion (sudden, severe vision loss), you need immediate referral to a stroke center or emergency department within 4.5-6 hours because this represents an eye "stroke" with 3-6% risk of cerebral stroke in the first 1-4 weeks and 20-24% concurrent stroke rate. 1, 2, 3
  • For patients over 50 years old with arterial occlusion, immediate blood tests (ESR and CRP) must be obtained to rule out Giant Cell Arteritis (GCA), which requires emergency high-dose corticosteroids to prevent blindness in the other eye. 1, 4, 3

Urgent Evaluation for Venous Occlusion

  • If this is a retinal vein occlusion (more gradual vision loss with hemorrhages), you need ophthalmologic examination every 4-6 weeks for the first 6 months to monitor for neovascularization that can cause devastating neovascular glaucoma. 1
  • This includes slit-lamp examination and undilated gonioscopy to detect iris or angle neovascularization. 1

Critical Systemic Workup

Cardiovascular and Stroke Risk Assessment

  • All patients with retinal vascular occlusion need urgent cardiovascular evaluation because up to 70% have clinically significant carotid stenosis, and the mortality rate is higher than age-matched controls due to cardiovascular disease. 1
  • Brain MRI with diffusion-weighted imaging should be performed within 7 days, as 19-25% of patients have silent brain infarctions that predict future stroke risk. 1

Risk Factor Optimization

The following conditions must be identified and aggressively managed: 1

  • Hypertension (most common risk factor for branch retinal vein occlusion)
  • Diabetes mellitus (major risk factor for both arterial and venous occlusions)
  • Hyperlipidemia (associated with retinal emboli and vascular disease)
  • Glaucoma (most common ocular association with central retinal vein occlusion)
  • Carotid artery disease (present in 45% of arterial occlusion patients)
  • Sleep apnea (risk factor for central retinal vein occlusion)
  • Smoking cessation (critical modifiable risk factor)

Special Considerations for Younger Patients

  • If you are under 50 years old, additional testing for vasculitis and hypercoagulability disorders (protein C, protein S, antithrombin III, antiphospholipid antibodies, homocysteine levels) should be performed, though the cost-effectiveness remains controversial. 1, 2

Vision-Threatening Complications Requiring Treatment

Macular Edema Management

For retinal vein occlusion with macular edema causing vision loss: 1, 5

  • Intravitreal anti-VEGF injections (ranibizumab) are FDA-approved and effective for macular edema following retinal vein occlusion
  • Macular grid laser photocoagulation is proven effective for branch retinal vein occlusion with visual acuity of 20/40 or worse
  • Intravitreal steroids are an alternative treatment option

Neovascularization Prevention and Treatment

If neovascularization develops (new abnormal blood vessels): 1

  • Panretinal photocoagulation (PRP) laser is the standard treatment to prevent progression to neovascular glaucoma and vitreous hemorrhage
  • Anti-VEGF injections can be used as adjunct therapy, especially when vitreous hemorrhage limits laser visibility
  • This complication occurs in approximately 25% of central retinal vein occlusion patients

Fellow Eye Risk and Long-Term Monitoring

Risk of Second Eye Involvement

  • With central retinal vein occlusion, you have a 1% per year risk of developing the same condition in the other eye. 1
  • With branch retinal vein occlusion, you have a 10% risk of developing any type of retinal vein occlusion in the other eye over 3 years. 1

Ongoing Surveillance

  • Regular ophthalmologic examinations are essential for life
  • Continued monitoring of systemic risk factors with your primary care physician
  • Immediate return if new visual symptoms develop in either eye

Critical Pitfalls to Avoid

Do not delay evaluation thinking vision will spontaneously improve - while some branch retinal vein occlusions show spontaneous improvement (37% gain two or more lines), arterial occlusions have less than 10% meaningful recovery without treatment, and both require urgent systemic evaluation. 1

Do not assume absence of visible emboli rules out embolic disease - the embolus may have fragmented or passed through, and cardiovascular workup is still mandatory. 1

Do not ignore asymptomatic retinal emboli if found - these carry increased stroke risk independent of conventional risk factors and warrant full cardiovascular evaluation. 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Retinal Artery Occlusion in Young Persons

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Distinguishing Retinal Arteritis from Retinal Phlebitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pathology and Pathogenesis of Retinal Vasculitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Retinal arteriolar emboli: epidemiology and risk of stroke.

Current opinion in ophthalmology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.